Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 102,799 0.900% | 102,799 (New Position) | Filing History |
| 2023-02-14 11:24 am Purchase | 2022-12-31 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 56,267 5.500% | 56,267 (New Position) | Filing History |
| 2022-08-10 4:17 pm Sale | 2022-08-09 | 13G | Evofem Biosciences, Inc. EVFM | Cox Todd Stewart | 0 0.000% | -31,359 (Position Closed) | Filing History |
| 2022-07-19 4:31 pm Purchase | 2022-06-30 | 13G | Evofem Biosciences, Inc. EVFM | Cox Todd Stewart | 31,359 9.290% | 31,359 (New Position) | Filing History |
| 2022-02-14 3:30 pm Sale | 2021-12-31 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 5,333 5.800% | -2,969 (-35.76%) | Filing History |
| 2021-09-10 4:36 pm Sale | 2021-08-31 | 13G | Evofem Biosciences, Inc. EVFM | MORGAN STANLEY MS | 105 0.100% | -3,965 (-97.42%) | Filing History |
| 2021-07-12 08:29 am Sale | 2021-06-30 | 13G | Evofem Biosciences, Inc. EVFM | BlackRock Inc. BLK | 1,811 2.300% | -970 (-34.87%) | Filing History |
| 2021-06-04 4:29 pm Purchase | 2021-05-25 | 13G | Evofem Biosciences, Inc. EVFM | MORGAN STANLEY MS | 4,070 5.100% | 4,070 (New Position) | Filing History |
| 2021-05-28 10:33 am Purchase | 2021-05-18 | 13G | Evofem Biosciences, Inc. EVFM | CVI Investments, Inc. | 8,303 9.900% | 8,303 (New Position) | Filing History |
| 2021-05-20 3:19 pm Sale | 2021-05-18 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 316 13.000% | -4,324 (-93.19%) | Filing History |
| 2021-04-27 3:31 pm Sale | 2021-04-22 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 4,639 8.400% | -614 (-11.68%) | Filing History |
| 2021-03-30 6:53 pm Sale | 2021-03-25 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 5,253 9.900% | -1,801 (-25.53%) | Filing History |
| 2021-02-12 11:21 am Sale | 2020-12-31 | 13G | Evofem Biosciences, Inc. EVFM | SCHRODER INVESTMENT MANAGEMENT NORTH AMERICA INC | 0 0.000% | -1,791 (Position Closed) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Evofem Biosciences, Inc. EVFM | BlackRock Inc. BLK | 2,781 6.400% | 1,776 (+176.77%) | Filing History |
| 2020-06-23 4:20 pm Sale | 2020-06-04 | 13G | Evofem Biosciences, Inc. EVFM | Link Fund Solutions Ltd | 0 0.000% | -4,874 (Position Closed) | Filing History |
| 2020-06-09 5:29 pm Purchase | 2020-06-04 | 13G | Evofem Biosciences, Inc. EVFM | ACACIA RESEARCH CORP ACTG | 1 0.002% | 1 (New Position) | Filing History |
| 2020-06-09 4:33 pm Sale | 2020-05-31 | 13G | Evofem Biosciences, Inc. EVFM | BlackRock Inc. BLK | 1,005 3.000% | -3,230 (-76.27%) | Filing History |
| 2020-06-09 06:58 am Purchase | 2020-06-05 | 13D | Evofem Biosciences, Inc. EVFM | Invesco Ltd. IVZ | 7,054 16.800% | 754 (+11.97%) | Filing History |
| 2020-05-26 4:34 pm Sale | 2020-05-21 | 13D | Evofem Biosciences, Inc. EVFM | PDL BIOPHARMA INC. PDLI | 1,778 6.300% | -7,111 (-80.00%) | Filing History |
| 2020-03-09 4:31 pm Purchase | 2020-02-29 | 13G | Evofem Biosciences, Inc. EVFM | BlackRock Inc. BLK | 4,235 17.000% | 4,235 (New Position) | Filing History |